The Life Science Manufacturers Association (LSMA) represents the companies that supply the tools, equipment, and technologies enabling Europes biotech and biomanufacturing ecosystem. LSMA welcomes the Biotech Act I and its ambition to strengthen Europes biotechnology ecosystem, enhance competitiveness, and increase manufacturing capacity within the EU.
LSM
Life Science Manufacturers Association
Industry association · Belgium · EU Transparency Register 2991748100513-45
3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
3
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 311 trade unions and professional associations on this site, they rank #123 by legislative files engaged — a count of participation, not a measure of influence.
0.9
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2025
in the register since
- Register category
- Trade unions and professional associations
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Life in PolicySpeak: request access →
Work at Life Science Manufacturers Association? so we know who speaks for it.
Their record over time
Life Science Manufacturers Association filed 3 positions between 13 Jan 2026 and 15 Jul 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 3 times.
What they argued
The Life Science Manufacturers Association (LSMA) welcomes the opportunity to contribute to the development of the EU Biotech Act II. Life science manufacturers are the companies that develop and supply the materials, consumables, equipment, and specialised services that make pharmaceutical, biotechnology, and diagnostic production possible.
The Life Sciences Manufacturers' Association (LSMA) welcomes the proposed Advanced Materials Act (AMA). We strongly support strengthening the EUs economic security and industrial competitiveness by boosting advanced materials research. However, the AMA must achieve these goals without placing disproportionate burdens on the highly regulated Life Sciences supply chain.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- Cefic · 3 files in common
- German Association of Biotechnology Industries (DIB) within the German Chemical Industry Association - VCI · 3 files in common
- BASF SE · 3 files in common
- EURAMET e.V. · 3 files in common
- VTT Technical Research Centre of Finland · 3 files in common
Showing 5 of 90.
Is this your organization?
Everything on this page comes from Life Science Manufacturers Association’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.